Free Trial
LON:BVXP

Bioventix (BVXP) Share Price, News & Analysis

Bioventix logo
GBX 2,400 -20.00 (-0.83%)
As of 11:57 AM Eastern

About Bioventix Stock (LON:BVXP)

Key Stats

Today's Range
2,400
2,510
50-Day Range
2,400
3,218
52-Week Range
2,400
4,800
Volume
12,934 shs
Average Volume
5,901 shs
Market Capitalization
£125.67 million
P/E Ratio
15.52
Dividend Yield
6.58%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

Remove Ads
Receive BVXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bioventix and its competitors with MarketBeat's FREE daily newsletter.

BVXP Stock News Headlines

3 top AIM stocks to consider buying before they recover
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's coming next. But here's the truth… This is just the beginning. Trump has made it clear his tariffs are coming, and that the market will get worse before it gets better. Luckily, our FREE Presidential Transition Guide details exactly what will happen in the next 100 days, and how to protect your hard-earned savings during these times. Don't wait for the next crash to wipe you out. Act now.
See More Headlines

BVXP Stock Analysis - Frequently Asked Questions

Bioventix's stock was trading at GBX 3,240 on January 1st, 2025. Since then, BVXP stock has decreased by 25.9% and is now trading at GBX 2,400.
View the best growth stocks for 2025 here
.

Bioventix PLC (LON:BVXP) released its earnings results on Monday, March, 31st. The biotechnology company reported $72.27 earnings per share (EPS) for the quarter. Bioventix had a net margin of 59.51% and a trailing twelve-month return on equity of 69.09%.

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Bioventix investors own include Lancashire (LRE), Avast (AVST), Victrex (VCT), boohoo group (BOO), Tullow Oil (TLW), Airbnb (ABNB) and Avon Protection (AVON).

Company Calendar

Last Earnings
3/31/2025
Today
4/01/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Cannabis
Current Symbol
LON:BVXP
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Trailing P/E Ratio
15.52
Forward P/E Ratio
14.43
P/E Growth
N/A
Net Income
£8.12 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£13.65 million
Cash Flow
GBX 77.70 per share
Price / Cash Flow
30.89
Book Value
GBX 229.94 per share
Price / Book
10.44

Miscellaneous

Free Float
N/A
Market Cap
£125.67 million
Optionable
Not Optionable
Beta
0.35
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (LON:BVXP) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners